TrialJCI insight2019
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.
Sharon Chinthrajah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled ittrialcites it